LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications

被引:0
|
作者
Meiling Yan
Jawahar L. Mehta
Weifang Zhang
Changping Hu
机构
[1] Central South University,Department of Pharmacology, School of Pharmaceutical Sciences
[2] University of Arkansas for Medical Sciences and the Central Arkansas Veterans Healthcare System,Division of Cardiovascular Medicine
来源
关键词
LOX-1; Diabetes; Cardiovascular complications; Nephropathy;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetes mellitus is a common metabolic disease characterized by a state of oxidative stress, inflammation and endothelial dysfunction. This malady can lead to a number of complications such as ischemic heart disease, nephropathy, neuropathy, retinopathy and impaired wound healing. The etiology of diabetic complications is multifactorial, and is closely associated with oxidative stress and inflammation. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a receptor for oxidized low density lipoprotein (ox-LDL), plays critical roles in multiple signal transduction pathways and is involved in the process of oxidative stress and inflammation. Recent studies provide important insights into the roles of LOX-1 in the development and progression of diabetic vasculopathy which is the underlying mechanism of diabetic complications. In this review, we summarize mechanistic studies, mainly related to LOX-1, on the development and progression of diabetes mellitus and its cardiovascular complications.
引用
收藏
页码:451 / 459
页数:8
相关论文
共 50 条
  • [1] LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications
    Yan, Meiling
    Mehta, Jawahar L.
    Zhang, Weifang
    Hu, Changping
    CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (05) : 451 - 459
  • [2] Oxidized LDL receptor LOX-1 and oxidative stress
    Sawamura, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 51P - 51P
  • [3] LOX-1 is a novel mediator of acute lung inflammation
    Fu, Jian
    Cheng, Lili
    Liang, Mei
    Zhang, Ping
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [4] Oxidative Stress and Inflammation in Diabetic Complications
    Vikram, Ajit
    Tripathi, Durga Nand
    Kumar, Ashutosh
    Singh, Sandeep
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [5] Oxidative stress and diabetic cardiovascular complications
    Jay, D
    Hitomi, H
    Griendling, KK
    FREE RADICAL BIOLOGY AND MEDICINE, 2006, 40 (02) : 183 - 192
  • [6] Recent novel approaches to limit oxidative stress and inflammation in diabetic complications
    Pickering, Raelene J.
    Rosado, Carlos J.
    Sharma, Arpeeta
    Buksh, Shareefa
    Tate, Mitchel
    de Haan, Judy B.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2018, 7 (04)
  • [7] LOX-1 AND DIABETIC NEUROPATHY IN MICE
    Vincent, A. M.
    McLean, L. L.
    Feldman, E. L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S143 - S144
  • [8] LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes
    Kelly, Katherine J.
    Wu, Pengfei
    Patterson, Carolyn E.
    Temm, Constance
    Dominguez, Jesus H.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 294 (05) : F1136 - F1145
  • [9] Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress
    Gu, Lei
    Bai, Wenli
    Li, Sha
    Zhang, Yuqing
    Han, Yi
    Gu, Yue
    Meng, Guoliang
    Xie, Liping
    Wang, Jing
    Xiao, Yujiao
    Shan, Liyang
    Zhou, Suming
    Wei, Lei
    Ferro, Albert
    Ji, Yong
    PLOS ONE, 2013, 8 (06):
  • [10] LOX-1 Is A Novel Mediator Of Neutrophil Dysfunction And Lung Inflammation In Sepsis
    Wu, Z.
    Fu, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183